Search results for "Lava"

showing 10 items of 456 documents

A barium method for the cytochemical detection of sulfated glycosaminoglycans in mast cells and basophilic leukocytes.

1999

Barium ions precipitate inorganic as well as organic sulfate compounds and they can be detected by a reaction with sodium rhodizonate. In this work, we describe the use of a barium method for the selective demonstration of sulfated glycosaminoglycans in cytoplasmic granules of mast cells and basophilic leukocytes. Methanol-fixed smears of mouse peritoneal mast cells and rat bone marrow basophils were treated with 5% BaCl2 for 10 min, followed by staining with either 0.2% sodium rhodizonate in 50% ethanol for 2 h at 60 degrees C, or 0.01% brilliant green in distilled water for 1 min. Light microscopic observation revealed a strong staining reaction of the cytoplasmic granules of these cell t…

MaleHistologychemistry.chemical_elementBone Marrow CellsCytoplasmic GranulesGlycosaminoglycanchemistry.chemical_compoundMiceSulfationmedicineAnimalsPeritoneal LavageMast CellsRats WistarColoring AgentsPeritoneal CavityGlycosaminoglycansMice Inbred BALB CCyclohexanonesHistocytochemistryBariumCell BiologyGeneral MedicineMast cellMolecular biologyStainingBasophilsRatsBasophilicQuaternary Ammonium Compoundsmedicine.anatomical_structureBiochemistryDistilled waterchemistryBrilliant greenBariumElectron Probe MicroanalysisActa histochemica
researchProduct

Migration of CD11b+ accessory cells during murine lung regeneration

2013

In many mammalian species, the removal of one lung leads to growth of the remaining lung to near-baseline levels. In studying post-pneumonectomy mice, we used morphometric measures to demonstrate neoalveolarization within 21 days of pneumonectomy. Of note, the detailed histology during this period demonstrated no significant pulmonary inflammation. To identify occult blood-borne cells, we used a parabiotic model (wild-type/GFP) of post-pneumonectomy lung growth. Flow cytometry of post-pneumonectomy lung digests demonstrated a rapid increase in the number of cells expressing the hematopoietic membrane molecule CD11b; 64.5% of the entire GFP(+) population were CD11b(+). Fluorescence microscop…

MaleLeukocyte migrationmedicine.medical_treatmentPopulationBiologyArticleGreen fluorescent proteinFlow cytometryMice03 medical and health sciencesPneumonectomy0302 clinical medicineCell MovementLeukocytesmedicineAnimalsRegenerationPneumonectomyeducationLung030304 developmental biologyMedicine(all)0303 health scienceseducation.field_of_studyBlood CellsCD11b AntigenLungmedicine.diagnostic_testHistologyGeneral MedicineCell BiologyMolecular biology3. Good healthMice Inbred C57BLHaematopoiesisPhenotypemedicine.anatomical_structureCD18 Antigens030220 oncology & carcinogenesisImmunologyTranscriptomeBronchoalveolar Lavage FluidDevelopmental BiologyStem Cell Research
researchProduct

Ethnobotanical investigation on wild medicinal plants in the Monti Sicani Regional Park (Sicily, Italy)

2014

Ethnopharmacological relevance The area of the "Monte Sicani Regional Park" (Central Western Sicily, southern Italy) has been quantitatively and extensively investigated in an ethnobotanical study for the first time. A total of 108 wild species are used for medicinal purposes, while, according to our study, the uses of 9 species have not previously been reported in ethnobotanical studies in Italy (e.g.; the use of Kickxia elatine (L.) Dumort. for the treatment of hyperhydrosis of the feet, the use of Lavatera agrigentina Tineo for cough and bronchitis). Aim of the study: The aim of this paper is to analyze, through quantitative indicators, the extent of the current knowledge on medicinal us…

MaleMediterranean climateHealth Knowledge Attitudes PracticeCultural identitycultural erosionEthnobotanyKickxia elatineMediterranean BasinDrug DiscoveryHumansKickxia elatine (L.) DumortMedicinal plantsSocioeconomicsMediterranean folk medicineSicilyAgedAged 80 and overPharmacologyEthnobotanical indexePlants MedicinalbiologyTraditional medicinebusiness.industryDrug Discovery3003 Pharmaceutical ScienceData CollectionSettore BIO/02 - Botanica Sistematicaethnobotanical indexesCultural erosionMiddle Agedbiology.organism_classificationSettore AGR/02 - Agronomia E Coltivazioni ErbaceeGeographyLavatera agrigentina TineoEthnobotanySettore BIO/03 - Botanica Ambientale E ApplicataFemaleLivestockLavaterabusinessHuman
researchProduct

Staphylococcus saprophyticus as an Unusual Agent of Nosocomial Pneumonia

1999

MaleMicrobiology (medical)MicrococcaceaeStaphylococcusPenicillinsPneumonia BacterialmedicineHumansCross InfectionStaphylococcus saprophyticusmedicine.diagnostic_testbiologybusiness.industryRespiratory diseaseMiddle AgedStaphylococcal Infectionsbiology.organism_classificationmedicine.diseasePneumoniaTreatment OutcomeInfectious DiseasesBronchoalveolar lavageLavage bronchoalveolaireLung diseaseInjections IntravenousImmunologybusinessBronchoalveolar Lavage FluidBacteriaClinical Infectious Diseases
researchProduct

Efficacy of Buffered Hypertonic Saline Nasal Irrigation for Nasal Symptoms in Children with Seasonal Allergic Rhinitis: A Randomized Controlled Trial

2017

<b><i>Background:</i></b> Saline nasal irrigation is labelled as an add-on treatment in patients with allergic rhinitis (AR). The primary aim of this study was to compare the efficacy of 21-day use of buffered hypertonic saline (BHS) versus normal saline solution (NSS) on reducing nasal symptoms in children with seasonal AR (SAR). Comparing their efficacy on nasal cytology counts (NCC), quality of life, and sleep quality was the secondary aim. <b><i>Methods:</i></b> In this 21-day,<b> </b>open-label, randomized controlled study, 36 SAR children (aged 6-13 years) with a Total 5 Symptom Score (T5SS) ≥5 received twice-daily BHS or NSS…

MaleNeutrophilsmedicine.medical_treatmentSodium ChlorideGastroenterologylaw.inventionPittsburgh Sleep Quality IndexLeukocyte Count0302 clinical medicineQuality of lifeRandomized controlled triallawSurveys and QuestionnairesBuffered hypertonic solutionImmunology and AllergyChild030223 otorhinolaryngologyChildrenSalineHypertonicRhinitisNasal symptomGeneral MedicineNasal irrigationTreatment OutcomeNasal cytologyFemaleSaline SolutionNasal symptomsQuality of lifemedicine.medical_specialtyAdolescentSeasonal allergic rhinitisImmunology03 medical and health sciencesAllergicBuffered hypertonic solution; Children; Nasal cytology; Nasal symptoms; Quality of life; Seasonal allergic rhinitis; Adolescent; Child; Eosinophils; Female; Humans; Leukocyte Count; Male; Nasal Lavage; Neutrophils; Quality of Life; Rhinitis Allergic Seasonal; Saline Solution Hypertonic; Sodium Chloride; Surveys and Questionnaires; Treatment Outcome; Immunology and Allergy; ImmunologyInternal medicinemedicineHumansSaline Solution HypertonicSeasonalbusiness.industryRhinitis Allergic SeasonalNasal symptomsHypertonic salineEosinophils030228 respiratory systemNasal cytologyImmunologyNasal LavagebusinessInternational Archives of Allergy and Immunology
researchProduct

Upregulation of activin-B and follistatin in pulmonary fibrosis: a translational study using human biopsies and a specific inhibitor in mouse fibrosi…

2014

Background: Activins are members of the TGF-ß superfamily of growth factors. First, we identified by expression array screening that activin-B and follistatin are upregulated in human idiopathic pulmonary fibrosis (IPF). Next, we wanted to clarify their specific role in lung fibrosis formation. Methods: We used specific antibodies for activin-A and -B subunits and follistatin to measure and localize their levels in idiopathic pulmonary fibrosis and control lung biopsies. To inhibit activin signaling, we used soluble activin type IIB receptor fused to the Fc portion of human IgG1 (sActRIIB-Fc) in two different mouse models of pulmonary fibrosis. Results: Activin-B and follistatin mRNA levels…

MalePathologyFollistatinPulmonary FibrosisPROTEINCell CountQuadriceps MuscleACTIVATIONIdiopathic pulmonary fibrosisMiceBMP-7FibrosisPulmonary fibrosisfollistatinInhibin-beta SubunitsGREMLINImmunity Cellularmedicine.diagnostic_testbiologyactivinsPIRFENIDONEPirfenidonerespiratory systemidiopathic pulmonary fibrosisMouse fibrosis model3. Good healthUp-RegulationActivinsmedicine.anatomical_structureACUTE EXACERBATIONmouse fibrosis modelembryonic structuresGROWTHBronchoalveolar Lavage Fluidhormones hormone substitutes and hormone antagonistsmedicine.drugResearch ArticleSignal TransductionPulmonary and Respiratory MedicineEXPRESSIONmedicine.medical_specialtyendocrine systemRecombinant Fusion ProteinseducationIdiopathic pulmonary fibrosisRespiratory MucosaAlveolar cellsINFLAMMATIONmedicineAnimalsHumansRNA MessengerLungbusiness.industrymedicine.diseaserespiratory tract diseasesMice Inbred C57BLPulmonary AlveoliDisease Models AnimalBronchoalveolar lavageProtein Biosynthesis3121 General medicine internal medicine and other clinical medicinebiology.proteinbusinessFollistatin
researchProduct

Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)

2016

The respiratory manifestations of eosinophilic granulomatosis with polyangiitis (EGPA) have not been studied in detail.In this retrospective multicentre study, EGPA was defined by asthma, eosinophilia and at least one new onset extra-bronchopulmonary organ manifestation of disease.The study population included 157 patients (mean±sd age 49.4±14.1 years), with a mean±sd blood eosinophil count of 7.4±6.4×109 L−1 at diagnosis. There was a mean±sd of 11.8±18.2 years from the onset of asthma to the diagnosis of EGPA, of 1.4±8.4 years from the first onset of peripheral eosinophilia to the diagnosis of EGPA, and of 7.4±6.4 years from EGPA diagnosis to the final visit. Despite inhaled and oral corti…

MalePediatricsAdministration OralDiseaseChurg-Strauss SyndromeBronchoalveolar LavageSeverity of Illness Index0302 clinical medicineAdrenal Cortex HormonesEosinophilicEosinophiliaAged 80 and overNomenclatureSystemic VasculitisCohortMiddle AgedTerm-follow-upPrognosis3. Good healthRespiratory Function TestsManagementTreatment OutcomeCohortAntineutrophil cytoplasmic antibodiesPopulation studyFemaleFrancemedicine.symptomGranulomatosis with polyangiitisConsensus conferencePulmonary and Respiratory MedicineAdultmedicine.medical_specialtyAdolescentVasculitides[ SDV.EE.SANT ] Life Sciences [q-bio]/Ecology environment/HealthGranulomatosis03 medical and health sciencesYoung AdultEosinophiliamedicineHumansAnti-neutrophil cytoplasmic antibodyAsthmaAgedRetrospective Studies030203 arthritis & rheumatology[SDV.EE.SANT]Life Sciences [q-bio]/Ecology environment/Healthbusiness.industryGranulomatosis with Polyangiitisasthmamedicine.diseaseEosinophils030228 respiratory systemImmunologybusinessTomography X-Ray Computed
researchProduct

Pre-clinical assessment of a water-in-fluorocarbon emulsion for the treatment of pulmonary vascular diseases

2019

Abstract Hypoxic pulmonary vasoconstriction (HPV) is a well-characterized vascular response to low oxygen pressures and is involved in life-threatening conditions such as high-altitude pulmonary edema (HAPE) and pulmonary arterial hypertension (PAH). While the efficacy of oral therapies can be affected by drug metabolism, or dose-limiting systemic toxicity, inhaled treatment via pressured metered dose inhalers (pMDI) may be an effective, nontoxic, practical alternative. We hypothesized that a stable water-in-perfluorooctyl bromide (PFOB) emulsion that provides solubility in common pMDI propellants, engineered for intrapulmonary delivery of pulmonary vasodilators, reverses HPV during acute h…

MalePulmonary CirculationDrug Evaluation PreclinicalPharmaceutical Science02 engineering and technologyPharmacology030226 pharmacology & pharmacyRats Sprague-DawleyDrug Delivery Systems0302 clinical medicineHypoxic pulmonary vasoconstrictionHigh-altitude pulmonary edemapulmonary hypertensionMedicineFluorocarbonsPhenylpropionatesmedicine.diagnostic_testGeneral Medicine021001 nanoscience & nanotechnologyPulmonary edema3. Good healthPyridazinesTreatment Outcomemedicine.anatomical_structureEmulsions0210 nano-technologyendothelinResearch Articlemedicine.drugpulmonary pressuresAmbrisentanambrisentanHypertension PulmonaryPulmonary Edema03 medical and health sciencesmedicine.arteryAnimalsAntihypertensive AgentsLungsodium nitriteperfluorocarbonbusiness.industrylcsh:RM1-950Watermedicine.diseasePulmonary hypertensionRatsBronchoalveolar lavagelcsh:Therapeutics. PharmacologyPulmonary arteryhigh altitude pulmonary edemabusinessDrug Delivery
researchProduct

Pre-treatment with mesenchymal stem cells reduces ventilator-induced lung injury

2012

ckground information: Bone marrow-derived mesenchymal stem cells (MSCs) reduce acute lung injury in animals challenged by bleomycin or bacterial lipopolysaccaride. It is not known, however, whether MSCs protect from ventilator- induced lung injury (VILI). Question of the study: Whether MSCs have a potential role in preventing or modulating VILI in healthy rats subjected to high-volume ventilation. Materials and methods: 24 Sprague-Dawley rats (250-300 g) were subjected to high- volume mechanical ventilation (25 ml/kg). MSCs (5x106) were intravenously or intratracheally administered (N=8 each) 30 min before starting over-ventilation and 8 rats were MSC-untreated. Spontaneously breathing anes…

MalePulmonary and Respiratory MedicinePathologymedicine.medical_specialtyAdministration TopicalVentilator-Induced Lung Injurymedicine.medical_treatmentVascular Cell Adhesion Molecule-1Pulmonary EdemaSettore MED/10 - Malattie Dell'Apparato RespiratorioLung injuryMesenchymal Stem Cell TransplantationBleomycinRats Sprague-Dawley03 medical and health scienceschemistry.chemical_compound0302 clinical medicineAcute lung injury cell therapy injurious ventilation lung edema lung inflammation mechanical ventilationAnimalsMedicineMacrophageCell adhesionLung030304 developmental biologyMechanical ventilation0303 health sciencesmedicine.diagnostic_testbusiness.industryMesenchymal stem cellrespiratory systemRatsrespiratory tract diseasesDisease Models AnimalBronchoalveolar lavage030228 respiratory systemchemistryBreathingAdministration IntravenousInflammation MediatorsbusinessBronchoalveolar Lavage FluidEuropean Respiratory Journal
researchProduct

Attenuation by oralN-acetylcysteine of bleomycin-induced lung injury in rats

2001

Antioxidant therapy may be useful in diseases with impaired oxidant-antioxidant balance such as pulmonary fibrosis. This study examines the effect ofN-acetylcysteine (NAC) on bleomycin-induced lung fibrosis in rats.NAC (3 mmol·kg−1; oral) was given daily from 1 week prior to a single intratracheal instillation of bleomycin (2.5 U·kg−1) or saline, until 14 days postinstillation.NAC partially decreased the augmented collagen deposition in bleomycin-exposed rats (hydroxyproline content was 4,354±386 and 3,416±326 µg·lung−1in vehicle-treated and NAC-treated rats, respectively; p<0.05). The histological assessment using a semiquantitative score showed less collagen deposition and inflammatory…

MalePulmonary and Respiratory MedicinePathologymedicine.medical_specialtyTaurinePulmonary FibrosisAdministration OralPharmacologyLung injuryBleomycinRats Sprague-DawleyAcetylcysteineBleomycinchemistry.chemical_compoundHydroxyprolineFibrosisPulmonary fibrosismedicineAnimalsLungLungmedicine.diagnostic_testbusiness.industryFree Radical Scavengersrespiratory systemmedicine.diseaseGlutathioneAcetylcysteineRatsrespiratory tract diseasesBronchoalveolar lavagemedicine.anatomical_structurechemistrybusinessBronchoalveolar Lavage Fluidmedicine.drugEuropean Respiratory Journal
researchProduct